↓ Skip to main content

Zoledronic acid prevents decreases in bone mineral density in patients with prostate cancer undergoing combined androgen blockade

Overview of attention for article published in SpringerPlus, October 2014
Altmetric Badge

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
6 Mendeley